Evaluation of progression-free survival by blinded independent central review in patients with progressive, well-differentiated pancreatic neuroendocrine tumors treated with sunitinib or placebo

被引：0
|
作者：
Van Cutsem, E.
Seitz, J. F.
Raoul, J.
Valle, J. W.
Faivre, S. J.
Patyna, S.
Klademenos, D.
Lu, D.
Chao, R. C.
Raymond, E.
机构：
[1] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
[2] La Timone Univ Hosp, Marseille, France
[3] Ctr Eugene Marquis, Rennes, France
[4] European Univ Brittany, Rennes, France
[5] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England
[6] Hop Beaujon, Clichy, France
[7] Pfizer, La Jolla, CA USA
[8] Pfizer Oncol, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.249
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
249
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Evaluation of Progression-Free Survival by Blinded Independent Central Review in Patients With Progressive, Well-Differentiated Pancreatic Neuroendocrine Tumors Treated With Sunitinib or Placebo
    Hammel, Pascal
    Castellano, Daniel
    Van Cutsem, Eric
    Niccoli, Patricia
    Faivre, Sandrine
    Patyna, Shem
    Klademenos, Deno
    Lu, Dongrui Ray
    Chao, Richard
    Raymond, Eric
    PANCREAS, 2011, 40 (02) : 327 - 327
  • [2] EVALUATION OF PROGRESSION-FREE SURVIVAL (PFS) BY BLINDED INDEPENDENT CENTRAL REVIEW (BICR) IN PATIENTS (PTS) WITH PROGRESSIVE, WELL-DIFFERENTIATED PANCREATIC NEUROENDOCRINE TUMOURS (NET) TREATED WITH SUNITINIB (SU) OR PLACEBO
    van Cutsem, E.
    Dahan, L.
    Patyna, S.
    Klademenos, D.
    Lu, D. R.
    Chao, R.
    Faivre, S.
    Raymond, E.
    ANNALS OF ONCOLOGY, 2010, 21 : 235 - 235
  • [3] Progression-Free Survival (PFS) by Blinded Independent Central Review (BICR) and Updated Overall Survival (OS) of Sunitinib versus Placebo for Patients with Progressive, Unresectable, Well Differentiated Pancreatic Neuroendocrine Tumor (NET)
    Vinik, Aaron
    Van Cutsem, Eric
    Niccoli, Patricia
    Raoul, Jean-Luc
    Bang, Yung-Jue
    Borbath, Ivan
    Lombard-Bohas, Catherine
    Valle, Juan W.
    Metrakos, Peter
    Smith, Denis
    Chen, Jen-Shi
    Hoersch, Dieter
    Castellano, Daniel E.
    Kennecke, Hagen F.
    Picus, Joel
    Van Hazel, Guy
    Patyna, Shem
    Lu, Dongrui Ray
    Chao, Richard C.
    Raymond, Eric
    PANCREAS, 2012, 41 (02) : 350 - 350
  • [4] Updated overall survival (OS) and progression-free survival (PFS) by blinded independent central review (BICR) of sunitinib (SU) versus placebo (PBO) for patients (Pts) with advanced unresectable pancreatic neuroendocrine tumors (NET)
    Raymond, E.
    Niccoli, P.
    Raoul, J.
    Bang, Y.
    Borbath, I.
    Lombard-Bohas, C.
    Valle, J. W.
    Metrakos, P.
    Smith, D.
    Vinik, A.
    Chen, J.
    Hoersch, D.
    Castellano, D. E.
    Kennecke, H. F.
    Picus, J.
    Van Hazel, G.
    Lu, D.
    Chao, R. C.
    Patyna, S.
    Van Cutsem, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Updated Efficacy and Safety Outcomes for Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors Treated with Sunitinib
    Nicola Fazio
    Matthew Kulke
    Brad Rosbrook
    Kathrine Fernandez
    Eric Raymond
    Targeted Oncology, 2021, 16 : 27 - 35
  • [6] Updated Efficacy and Safety Outcomes for Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors Treated with Sunitinib
    Fazio, Nicola
    Kulke, Matthew
    Rosbrook, Brad
    Fernandez, Kathrine
    Raymond, Eric
    TARGETED ONCOLOGY, 2021, 16 (01) : 27 - 35
  • [7] The Efficacy and Safety of Sunitinib in Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (12) : 10 - 11
  • [8] The Efficacy and Safety of Sunitinib in Patients With Advanced Well-differentiated Pancreatic Neuroendocrine Tumors
    Raymond, Eric
    Kulke, Matthew
    Qin, Shukui
    Schenker, Michael
    Cubillo, Antonio
    Lou, Wenhui
    Tomasek, Jiri
    Thiis-Evensen, Espen
    Xu, Jianming
    Racz, Karoly
    Croitoru, Adina
    Khasraw, Mustafa
    Sedlackova, Eva
    Borbath, Ivan
    Ruff, Paul
    Oberstein, Paul
    Ito, Tetsuhide
    Fernandez, Kathrine
    Rosbrook, Brad
    Fazio, Nicola
    PANCREAS, 2017, 46 (03) : 435 - 435
  • [9] Blinded Independent Central Review of the Progression-Free Survival Endpoint
    Amit, Ohad
    Bushnell, Will
    Dodd, Lori
    Roach, Nancy
    Sargent, Daniel
    ONCOLOGIST, 2010, 15 (05): : 492 - 495
  • [10] Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors
    Dhall, Deepti
    Mertens, Richard
    Bresee, Catherine
    Parakh, Rugvedita
    Wang, Hanlin L.
    Li, Marissa
    Dhall, Girish
    Colquhoun, Steven D.
    Ines, Delma
    Chung, Fai
    Yu, Run
    Nissen, Nicholas N.
    Wolin, Edward
    HUMAN PATHOLOGY, 2012, 43 (04) : 489 - 495
12345